{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:19:53Z","timestamp":1794935993145,"version":"4.9.1"},"reference-count":149,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.eururo.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T03:56:47Z","timestamp":1654919807000},"page":"387-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"title":["European Association of Urology Guidelines on Male Urinary Incontinence"],"prefix":"10.1016","volume":"82","author":[{"given":"Mauro","family":"Gacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios I.","family":"Sakalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Karavitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.W.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iason","family":"Kyriazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Malde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Mamoulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Speakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari A.O.","family":"Tikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Gravas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2022.05.012_b0005","series-title":"Incontinence","article-title":"Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal incontinence (AI)","author":"Milsom","year":"2013"},{"key":"10.1016\/j.eururo.2022.05.012_b0010","unstructured":"Burkhard FC, et al. EAU guidelines on urinary incontinence in adults. In: EAU Guidelines. Presented at the annual EAU Congress 2018; Copenhagen, Denmark; 2017."},{"key":"10.1016\/j.eururo.2022.05.012_b0015","unstructured":"Abrams P, et al. 5th International Consultation on Incontinence; February 2012; Paris, France."},{"key":"10.1016\/j.eururo.2022.05.012_b0020","doi-asserted-by":"crossref","unstructured":"Gravas S, et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). Arnhem, the Netherlands; 2022.","DOI":"10.1016\/j.euf.2022.03.006"},{"key":"10.1016\/j.eururo.2022.05.012_b0025","unstructured":"Phillips B, et al. Oxford Centre for Evidence-based Medicine: levels of evidence. 1998. Updated by Jeremy Howick; March 2009."},{"key":"10.1016\/j.eururo.2022.05.012_b0030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2022.05.012_b0035","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2022.05.012_b0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/nau.23897","article-title":"The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction","volume":"38","author":"D'Ancona","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.juro.2018.02.075","article-title":"Prevalence and characteristics of urinary incontinence in a treatment seeking male prospective cohort: results from the LURN study","volume":"200","author":"Helfand","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0050","first-page":"145","article-title":"Male urinary incontinence: prevalence, risk factors, and preventive interventions","volume":"11","author":"Shamliyan","year":"2009","journal-title":"Rev Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.eururo.2014.01.019","article-title":"What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women","volume":"65","author":"Agarwal","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2020.12.019","article-title":"A systematic review of patients' values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms","volume":"79","author":"Malde","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0065","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.juro.2006.07.029","article-title":"The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination survey","volume":"176","author":"Anger","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-132-7-200004040-00006","article-title":"Urinary incontinence among male veterans receiving care in primary care clinics","volume":"132","author":"Smoger","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2022.05.012_b0075","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archinte.166.10.1128","article-title":"Management of urinary incontinence in Medicare managed care beneficiaries: results from the 2004 Medicare Health Outcomes Survey","volume":"166","author":"Mardon","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eururo.2022.05.012_b0080","series-title":"Campbell\u2019s Urology","article-title":"The treatment of male urinary incontinence","author":"Hadley","year":"1986"},{"key":"10.1016\/j.eururo.2022.05.012_b0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00120-010-2263-2","article-title":"Epidemiology and etiology of male urinary incontinence","volume":"49","author":"Hampel","year":"2010","journal-title":"Urologe A"},{"key":"10.1016\/j.eururo.2022.05.012_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00192-012-1827-7","article-title":"Responsiveness of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire in women undergoing treatment for pelvic floor disorders","volume":"24","author":"Chan","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.eururo.2022.05.012_b0095","first-page":"e647","article-title":"1576 Is there a relationship between Incontinence Impact Questionnaire 7 score after surgery for stress urinary incontinence and patient-perceived satisfaction and improvement?","volume":"189","author":"Kim","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1308\/003588414X13946184903847","article-title":"Patient reported outcome measures in male incontinence surgery","volume":"96","author":"Tran","year":"2014","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.eururo.2022.05.012_b0105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2014.02.057","article-title":"Developing and validating the International Consultation on Incontinence Questionnaire bladder diary","volume":"66","author":"Bright","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/nau.20778","article-title":"Urine production and bladder diary measurements in women with type 2 diabetes mellitus and their relation to lower urinary tract symptoms and voiding dysfunction","volume":"29","author":"Fayyad","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2010.06.044","article-title":"Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score","volume":"77","author":"Homma","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b0120","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.juro.2009.01.042","article-title":"Women overestimate daytime urinary frequency: the importance of the bladder diary","volume":"181","author":"Stav","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/nau.10162","article-title":"The association between overactive bladder symptoms and objective parameters from bladder diary and filling cystometry","volume":"23","author":"van Brummen","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0130","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/jama.280.23.1995","article-title":"Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial","volume":"280","author":"Burgio","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2022.05.012_b0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s001920070020","article-title":"Measurement of postvoid residual urine with portable transabdominal bladder ultrasound scanner and urethral catheterization","volume":"11","author":"Goode","year":"2000","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.eururo.2022.05.012_b0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00296729","article-title":"Variability of post-void residual urine volume in the elderly","volume":"24","author":"Griffiths","year":"1996","journal-title":"Urol Res"},{"key":"10.1016\/j.eururo.2022.05.012_b0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0090-4295(97)00293-8","article-title":"Three-dimensional ultrasound device for rapid determination of bladder volume","volume":"50","author":"Marks","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF01902376","article-title":"Postvoid residual volume cannot be accurately estimated by bimanual examination","volume":"7","author":"Nygaard","year":"1996","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.eururo.2022.05.012_b0155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1532-5415.1994.tb06987.x","article-title":"Use of a portable ultrasound device to measure post-void residual volume among incontinent nursing home residents","volume":"42","author":"Ouslander","year":"1994","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2022.05.012_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-5347(17)40572-6","article-title":"The accuracy of a catheterized residual urine","volume":"141","author":"Stoller","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.archger.2011.07.012","article-title":"Clinical presentation of urinary tract infection (UTI) differs with aging in women","volume":"55","author":"Arinzon","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.eururo.2022.05.012_b0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0b013e318160d64a","article-title":"Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women","volume":"111","author":"Moore","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eururo.2022.05.012_b0175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-122-10-199505150-00003","article-title":"Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents?","volume":"122","author":"Ouslander","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2022.05.012_b0180","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1742-1241.2009.02078.x","article-title":"Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence","volume":"63","author":"Wyman","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eururo.2022.05.012_b0185","doi-asserted-by":"crossref","first-page":"73.e1","DOI":"10.1016\/j.ajog.2011.02.054","article-title":"Fluid intake and risk of stress, urgency, and mixed urinary incontinence","volume":"205","author":"Townsend","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eururo.2022.05.012_b0190","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.eururo.2018.10.027","article-title":"Prevalence of and risk factors for urinary incontinence in home hospice patients","volume":"75","author":"Chughtai","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2016.12.018","article-title":"Polypharmacy in older adults: Association Rule and Frequent-Set Analysis to evaluate concomitant medication use","volume":"116","author":"Held","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.eururo.2022.05.012_b0200","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1532-5415.2010.02978.x","article-title":"A controlled trial of an intervention to improve urinary and fecal incontinence and constipation","volume":"58","author":"Schnelle","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2022.05.012_b0205","doi-asserted-by":"crossref","DOI":"10.3310\/hta12290","article-title":"Absorbent products for urinary\/faecal incontinence: a comparative evaluation of key product designs","volume":"12","author":"Fader","year":"2008","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.eururo.2022.05.012_b0210","first-page":"CD004997","article-title":"Types of indwelling urinary catheters for long-term bladder drainage in adults","volume":"10","author":"Jahn","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.05.012_b0215","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/nau.22356","article-title":"Long-term bladder drainage: suprapubic catheter versus other methods: a scoping review","volume":"32","author":"Hunter","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0220","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1016\/S1569-9056(14)60751-X","article-title":"Catheter designs, techniques and strategies for intermittent catheterisation: what is the evidence for preventing symptomatic UTI and other complications? A Cochrane systematic review","volume":"13","author":"Prieto","year":"2014","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2022.05.012_b0225","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bju.13016","article-title":"A trial of devices for urinary incontinence after treatment for prostate cancer","volume":"116","author":"Macaulay","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0230","first-page":"CD002113","article-title":"Prompted voiding for the management of urinary incontinence in adults","volume":"2","author":"Eustice","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.05.012_b0235","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1447-0594.2012.00875.x","article-title":"Systematic review of care intervention studies for the management of incontinence and promotion of continence in older people in care homes with urinary incontinence as the primary focus (1966\u20132010)","volume":"12","author":"Flanagan","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0240","first-page":"CD002801","article-title":"Habit retraining for the management of urinary incontinence in adults","volume":"2004","author":"Ostaszkiewicz","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.05.012_b0245","first-page":"CD003193","article-title":"Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults","volume":"12","author":"Rai","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.05.012_b0250","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/ptj\/pzy101","article-title":"Effectiveness of pelvic floor muscle training alone and in combination with biofeedback, electrical stimulation, or both compared to control for urinary incontinence in men following prostatectomy: systematic review and meta-analysis","volume":"98","author":"Kannan","year":"2018","journal-title":"Phys Ther"},{"key":"10.1016\/j.eururo.2022.05.012_b0255","doi-asserted-by":"crossref","first-page":"e1420","DOI":"10.1111\/ijcp.14208","article-title":"A biofeedback-guided programme or pelvic floor muscle electric stimulation can improve early recovery of urinary continence after radical prostatectomy: a meta-analysis and systematic review","volume":"75","author":"Sciarra","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.eururo.2022.05.012_b0260","first-page":"CD001843","article-title":"Conservative management for postprostatectomy urinary incontinence","volume":"1","author":"Anderson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.05.012_b0265","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0140-6736(11)60751-4","article-title":"Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials","volume":"378","author":"Glazener","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2022.05.012_b0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12894-019-0570-5","article-title":"Preoperative pelvic floor muscle exercise for early continence after holmium laser enucleation of the prostate: a randomized controlled study","volume":"20","author":"Anan","year":"2020","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0275","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/nau.23300","article-title":"The effects of Pilates method on pelvic floor muscle strength in patients with post-prostatectomy urinary incontinence: a randomized clinical trial","volume":"37","author":"Gomes","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0280","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/0269215519893096","article-title":"Does trunk muscle training with an oscillating rod improve urinary incontinence after radical prostatectomy? A prospective randomized controlled trial","volume":"34","author":"Heydenreich","year":"2020","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.eururo.2022.05.012_b0285","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/nau.24389","article-title":"Early 3-month treatment with comprehensive physical therapy program restores continence in urinary incontinence patients after radical prostatectomy: a randomized controlled trial","volume":"39","author":"Soto Gonzalez","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0290","first-page":"147","article-title":"A comparative study of whole body vibration training and pelvic floor muscle training on women's stress urinary incontinence: three- month follow-up","volume":"9","author":"Farzinmehr","year":"2015","journal-title":"J Family Reprod Health"},{"key":"10.1016\/j.eururo.2022.05.012_b0295","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/nau.24740","article-title":"Efficacy of transcutaneous perineal electrostimulation versus intracavitary anal electrostimulation in the treatment of urinary incontinence after a radical prostatectomy: randomized controlled trial","volume":"40","author":"Pan\u00e9-Alemany","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0300","first-page":"CD001202","article-title":"Electrical stimulation with non-implanted electrodes for urinary incontinence in men","volume":"6","author":"Berghmans","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.05.012_b0305","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.23843","article-title":"Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: randomized control trial","volume":"38","author":"Ram\u00edrez-Garc\u00eda","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0310","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.juro.2010.09.030","volume":"185","author":"Civic","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0315","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s00192-020-04429-8","article-title":"Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis","volume":"31","author":"Wang","year":"2020","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.eururo.2022.05.012_b1111","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2006.10.005","article-title":"Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladder","volume":"51","author":"Dmochowski","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b2222","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.urology.2009.09.007","article-title":"Efficacy and tolerability of fesoterodine in men with overactive bladder: a pooled analysis of 2 phase III studies","volume":"75","author":"Herschorn","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b3333","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00345-007-0212-5","article-title":"Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia","volume":"25","author":"H\u00f6fner","year":"2007","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b4444","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1464-410X.2006.06068.x","article-title":"Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence","volume":"97","author":"Roehrborn","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b5555","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2022.05.012_b6666","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/01.ju.0000181823.33224.a0","article-title":"Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"174","author":"Kaplan","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b7777","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b8888","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/13685530903440408","article-title":"Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes","volume":"13","author":"Kaplan","year":"2010","journal-title":"Aging Male"},{"key":"10.1016\/j.eururo.2022.05.012_b0345","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.urology.2008.06.067","article-title":"Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB","volume":"72","author":"Roehrborn","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b0320","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/iju.13498","article-title":"Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms\/overactive bladder: comparison with placebo and tolterodine","volume":"25","author":"Sebastianelli","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/luts.12053","article-title":"Efficacy and safety of the selective beta3-adrenoceptor agonist mirabegron in Japanese patients with overactive bladder: a randomized, double-blind, placebo-controlled, dose-finding study","volume":"7","author":"Yamaguchi","year":"2015","journal-title":"Low Urin Tract Symptoms"},{"key":"10.1016\/j.eururo.2022.05.012_b0330","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.eururo.2016.02.030","article-title":"Efficacy and safety of mirabegron add-on therapy to solifenacin in incontinent overactive bladder patients with an inadequate response to initial 4-week solifenacin monotherapy: a randomised double-blind multicentre phase 3B study (BESIDE)","volume":"70","author":"Drake","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0335","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/nau.22645","article-title":"Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a beta3-adrenoceptor agonist, in patients with overactive bladder in Asia","volume":"34","author":"Kuo","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b9999","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00345-016-1908-1","volume":"35","author":"Abrams","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11934-015-0531-9","article-title":"Tolterodine in the treatment of male LUTS","volume":"16","author":"Gacci","year":"2015","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.eururo.2022.05.012_b0350","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/00365590902836740","article-title":"Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study","volume":"43","author":"Yokoyama","year":"2009","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2022.05.012_b0355","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0360","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/bju.13068","article-title":"Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study)","volume":"116","author":"Yamaguchi","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0365","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.juro.2013.05.062","article-title":"Urodynamics and safety of the beta(3)-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction","volume":"190","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0370","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.euf.2020.06.007","article-title":"Use of duloxetine for postprostatectomy stress urinary incontinence: a systematic review","volume":"7","author":"Kotecha","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2022.05.012_b0375","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/nau.24102","article-title":"Bulking for stress urinary incontinence in men: a systematic review","volume":"38","author":"Toia","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0380","doi-asserted-by":"crossref","unstructured":"Choini\u00e8re R, et al. Evaluation of benefits and harms of surgical treatments for post-radical prostatectomy urinary incontinence: a systematic review and meta-analysis. Eur Urol Focus. In press. https:\/\/doi.org\/10.1016\/j.euf.2021.09.007.","DOI":"10.1016\/j.euf.2021.09.007"},{"key":"10.1016\/j.eururo.2022.05.012_b0385","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eururo.2004.08.019","article-title":"The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence","volume":"47","author":"Imamoglu","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0390","first-page":"S57","article-title":"A propensity score-matching analysis comparing bulking agent with sling implantation for the treatment of postprostatectomy stress urinary incontinence","volume":"38","author":"Sacco","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0395","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/nau.23299","article-title":"Results of an innovative bulking agent in patients with stress urinary incontinence who are not optimal candidates for mid-urethral sling surgery","volume":"37","author":"Kowalik","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0400","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/00005392-199805000-00025","article-title":"Delayed hypersensitivity and systemic arthralgia following transurethral collagen injection for stress urinary incontinence","volume":"159","author":"Stothers","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0405","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1001\/jama.1984.03340480059030","article-title":"Migration and granulomatous reaction after periurethral injection of polytef (Teflon)","volume":"251","author":"Malizia","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2022.05.012_b0410","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0022-5347(05)65767-9","article-title":"Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence","volume":"166","author":"Pannek","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0415","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bjmsu.2010.01.006","article-title":"The male sling for post-radical prostatectomy urinary incontinence: urethral compression versus urethral relocation or what is next?","volume":"3","author":"Zeif","year":"2010","journal-title":"Br J Med Surg Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0420","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.21037\/tau-20-1459","article-title":"Narrative review of male urethral sling for post-prostatectomy stress incontinence: sling type, patient selection, and clinical applications","volume":"10","author":"Bole","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0425","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1089\/end.2015.0292","article-title":"Retropubic intracorporeal placement of a suburethral autologous sling during robot-assisted radical prostatectomy to improve early urinary continence recovery: preliminary data","volume":"29","author":"Cestari","year":"2015","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2022.05.012_b0430","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.urology.2013.09.059","article-title":"Bladder neck sling suspension during robot-assisted radical prostatectomy to improve early return of urinary continence: a comparative analysis","volume":"83","author":"Kojima","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b0435","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.juro.2016.08.122","article-title":"A randomized study of intraoperative autologous retropubic urethral sling on urinary control after robotic assisted radical prostatectomy","volume":"197","author":"Nguyen","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0440","doi-asserted-by":"crossref","first-page":"eRW4508","DOI":"10.31744\/einstein_journal\/2019RW4508","article-title":"Adjustable sling for the treatment of post-prostatectomy urinary incontinence: systematic review and meta-analysis","volume":"17","author":"da Silva","year":"2019","journal-title":"Einstein (Sao Paulo, Brazil)"},{"key":"10.1016\/j.eururo.2022.05.012_b0445","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.urology.2010.07.541","article-title":"Results of the AdVance transobturator male sling after radical prostatectomy and adjuvant radiotherapy","volume":"77","author":"Bauer","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b0450","first-page":"8998","article-title":"Transobturator sling for post-prostatectomy incontinence: radiation's effect on efficacy\/satisfaction","volume":"24","author":"Wright","year":"2017","journal-title":"Can J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0455","doi-asserted-by":"crossref","DOI":"10.1177\/1756287219875581","article-title":"Effectiveness of surgical management with an adjustable sling versus an artificial urinary sphincter in patients with severe urinary postprostatectomy incontinence: a systematic review and network meta-analysis","volume":"11","author":"Guacheta Bomba","year":"2019","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0460","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.purol.2017.09.010","article-title":"Long-term outcomes of I-Stop TOMSTM male sling implantation for post-prostatectomy incontinence management","volume":"27","author":"Malval","year":"2017","journal-title":"Prog Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0465","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.eururo.2021.01.024","article-title":"Outcomes of a noninferiority randomised controlled trial of surgery for men with urodynamic stress incontinence after prostate surgery (MASTER)","volume":"79","author":"Abrams","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0470","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.euf.2019.01.008","article-title":"Male slings for postprostatectomy incontinence: a systematic review and meta-analysis","volume":"6","author":"Meisterhofer","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2022.05.012_b0475","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1464-410X.2010.09765.x","article-title":"Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors","volume":"108","author":"Cornu","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0480","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/nau.24101","article-title":"Extended follow-up of the AdVance XP male sling in the treatment of male urinary stress incontinence after 48 months: results of a prospective and multicenter study","volume":"38","author":"Grabbert","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0485","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","article-title":"Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence","volume":"29","author":"Abrams","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0490","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.juro.2009.08.159","article-title":"Patient perceived effectiveness of a new male sling as treatment for post-prostatectomy incontinence","volume":"183","author":"Gill","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0495","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/j.1464-410X.2010.09400.x","article-title":"The 1 year outcome of the transobturator retroluminal repositioning sling in the treatment of male stress urinary incontinence","volume":"106","author":"Rehder","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0500","first-page":"585","article-title":"Long-term follow-up for the treatment of male urinary incontinence with the Remeex system","volume":"40","author":"Navalon-Monllor","year":"2016","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.eururo.2022.05.012_b0505","first-page":"O111","article-title":"Short-term evaluation of the adjustable bulbourethral male sling for post-prostatectomy urinary incontinence","volume":"11","author":"Shamout","year":"2019","journal-title":"Low Urin Tract Symptoms"},{"key":"10.1016\/j.eururo.2022.05.012_b0510","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12325-018-0852-4","article-title":"Effectiveness of Adjustable Transobturator Male System (ATOMS) to treat male stress incontinence: a systematic review and meta-analysis","volume":"36","author":"Esquinas","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.eururo.2022.05.012_b0515","doi-asserted-by":"crossref","first-page":"e0225762","DOI":"10.1371\/journal.pone.0225762","article-title":"Systematic review and meta-analysis comparing Adjustable Transobturator Male System (ATOMS) and Adjustable Continence Therapy (ProACT) for male stress incontinence","volume":"14","author":"Abellan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2022.05.012_b0520","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1590\/S1677-5538.IBJU.2015.0075","article-title":"Argus T\u00ae versus Advance\u00ae Sling for postprostatectomy urinary incontinence: a randomized clinical trial","volume":"42","author":"Lima","year":"2016","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0525","first-page":"209","article-title":"Long term follow-up of readjustable urethral sling procedure (Remeex System) for male stress urinary incontinence","volume":"30","author":"Kim","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0530","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.juro.2010.11.075","article-title":"An adjustable sling for the treatment of all degrees of male stress urinary incontinence: retrospective evaluation of efficacy and complications after a minimal followup of 14 months","volume":"185","author":"Bochove-Overgaauw","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0535","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.juro.2011.03.131","article-title":"Mid-term complications after placement of the male adjustable suburethral sling: a single center experience","volume":"186","author":"Dalpiaz","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0540","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.euf.2017.11.007","article-title":"Surgical treatment of male postprostatectomy incontinence: current concepts","volume":"3","author":"Kretschmer","year":"2017","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2022.05.012_b0545","doi-asserted-by":"crossref","first-page":"e0130867","DOI":"10.1371\/journal.pone.0130867","article-title":"Surgical treatment for urinary incontinence after prostatectomy: a meta-analysis and systematic review","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2022.05.012_b0550","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/nau.23221","article-title":"Long-term outcomes of primary implantation and revisions of artificial urinary sphincter in men with stress urinary incontinence","volume":"36","author":"Suh","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0555","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/nau.23119","article-title":"Prospective follow-up study of artificial urinary sphincter placement preserving the bulbospongiosus muscle","volume":"36","author":"Serra","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0560","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.juro.2016.03.076","article-title":"Long-term quality of life and functional outcomes among primary and secondary artificial urinary sphincter implantations in men with stress urinary incontinence","volume":"196","author":"Viers","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0565","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bju.12848","article-title":"Long-term functional outcomes after artificial urinary sphincter implantation in men with stress urinary incontinence","volume":"115","author":"L\u00e9on","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0570","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.urology.2007.09.009","article-title":"A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes","volume":"71","author":"Trigo Rocha","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b0575","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.urology.2008.10.037","article-title":"Urodynamic testing in evaluation of postradical prostatectomy incontinence before artificial urinary sphincter implantation","volume":"73","author":"Lai","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b0580","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/nau.24444","article-title":"High\/low-volume center experience predicts outcome of AMS 800 in male stress incontinence: results of a large middle European multicenter case series","volume":"39","author":"Queissert","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0585","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bju.14955","article-title":"A national study of artificial urinary sphincter and male sling implantation after radical prostatectomy in England","volume":"125","author":"Dosanjh","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0590","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.eururo.2012.11.034","article-title":"The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence","volume":"63","author":"Van der Aa","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0595","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5213\/inj.1938032.016","article-title":"Artificial urinary sphincter cuff size predicts outcome in male patients treated for stress incontinence: results of a large central European multicenter cohort study","volume":"23","author":"Queissert","year":"2019","journal-title":"Int Neurourol J"},{"key":"10.1016\/j.eururo.2022.05.012_b0600","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.juro.2017.08.077","article-title":"Surgical and patient reported outcomes of artificial urinary sphincter implantation: a multicenter, prospective, observational study","volume":"199","author":"Kaiho","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0605","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/bju.15197","article-title":"Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study","volume":"127","author":"Sacco","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0610","first-page":"263","article-title":"Preliminary outcomes of the European multicentre experience with the ZSI 375 artificial urinary sphincter for treatment of stress urinary incontinence in men","volume":"72","author":"Ostrowski","year":"2019","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0615","first-page":"263","article-title":"Urinary artificial sphincter ZSI 375 for treatment of stress urinary incontinence in men: 5 and 7 years follow-up report","volume":"84","author":"Llorens","year":"2017","journal-title":"Urol J"},{"key":"10.1016\/j.eururo.2022.05.012_b0620","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1590\/s1677-5538.ibju.2018.0128","article-title":"Artificial sphincter \u201cBR - SL - AS 904\u201d in the treatment of urinary incontinence after radical prostatectomy: efficacy, practicality and safety in a prospective and multicenter study","volume":"44","author":"de Barros","year":"2018","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0625","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/nau.24135","article-title":"Adjustable continence therapy (ProACT) for the treatment of male stress urinary incontinence: a systematic review and meta-analysis","volume":"38","author":"Larson","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2022.05.012_b0630","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1442-2042.2008.02161.x","article-title":"Adjustable continence therapy (ProACT) and bone anchored male sling: comparison of two new treatments of post prostatectomy incontinence","volume":"15","author":"Crivellaro","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0635","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.juro.2011.03.016","article-title":"Management of stress urinary incontinence following prostate surgery with minimally invasive adjustable continence balloon implants: functional results from a single center prospective study","volume":"186","author":"Roupret","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0640","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrurol.2015.169","article-title":"New intraprostatic injectables and prostatic urethral lift for male LUTS","volume":"12","author":"Magistro","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0645","first-page":"CD005493","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","volume":"12","author":"Duthie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2022.05.012_b0650","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2011.07.001","article-title":"Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of Botox (onabotulinumtoxinA) and Dysport (abobotulinumtoxinA)","volume":"60","author":"Mangera","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0655","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0660","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bju.13945","article-title":"Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis","volume":"120","author":"Drake","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0665","first-page":"7217","article-title":"Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia","volume":"21","author":"Chughtai","year":"2014","journal-title":"Can J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0670","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.urology.2018.09.016","article-title":"Onabotulinum toxin A Injections in Men With Refractory Idiopathic Detrusor Overactivity","volume":"123","author":"Faure Walker","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2022.05.012_b0675","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000351037","article-title":"Botulinum toxin-A injections for idiopathic overactive bladder: a systematic review and meta-analysis","volume":"91","author":"Cui","year":"2013","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2022.05.012_b0680","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.euf.2020.08.015","article-title":"Long-term follow-up of intravesical onabotulinum toxin-A injections in male patients with idiopathic overactive bladder: comparing surgery-na\u00efve patients and patients after prostate surgery","volume":"7","author":"Bels","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2022.05.012_b0685","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.eururo.2017.11.002","article-title":"Efficacy and safety of sacral and percutaneous tibial neuromodulation in non-neurogenic lower urinary tract dysfunction and chronic pelvic pain: a systematic review of the literature","volume":"73","author":"Tutolo","year":"2018","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2022.05.012_b0690","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000052275","article-title":"Long-term results of augmentation cystoplasty","volume":"34","author":"Venn","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0695","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.aju.2013.07.003","article-title":"The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty","volume":"11","author":"El-Azab","year":"2013","journal-title":"Arab J Urol"},{"key":"10.1016\/j.eururo.2022.05.012_b0700","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/nau.23205","article-title":"Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: a systematic review","volume":"36","author":"Hoen","year":"2017","journal-title":"Neurourol Urodyn"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283822023867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283822023867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:11:46Z","timestamp":1759583506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283822023867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":149,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0302283822023867"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2022.05.012","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Association of Urology Guidelines on Male Urinary Incontinence","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}